HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE T-HELPER EPITOPES IDENTIFIED IN MICE AND HUMANS - CORRELATION WITH A CYTOTOXIC T-CELL EPITOPE

被引:34
作者
DEGROOT, AS
CLERICI, M
HOSMALIN, A
HUGHES, SH
BARND, D
HENDRIX, CW
HOUGHTEN, R
SHEARER, GM
BERZOFSKY, JA
机构
[1] NCI, METAB BRANCH, MOLEC IMMUNOGENET & VACCINE RES SECT, BETHESDA, MD 20892 USA
[2] NCI, EXPTL IMMUNOL BRANCH, BETHESDA, MD 20892 USA
[3] NCI, FREDERICK CANC RES FACIL, ABL BASIC RES PROGRAM, FREDERICK, MD 21701 USA
[4] DEV CTR, FREDERICK, MD USA
[5] USAF, MED CTR, HIV UNIT, LACKLAND AFB, TX 78236 USA
[6] TORREY PINES INST MOLEC STUDIES, SAN DIEGO, CA USA
关键词
D O I
10.1093/infdis/164.6.1058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell immunity may be critical to development of a vaccine for human immunodeficiency virus (HIV-1). T helper epitopes were identified in three predominantly conserved regions in the HIV-1 reverse transcriptase by using reverse transcriptase-immunized mice of five major histocompatibility complex haplotypes. One peptide (residues 38-52) that stimulated H-2k T cells also contained an epitope recognized by cytotoxic T cells from the same mice and from HIV-infected patients. Such concordance between helper and cytotoxic T lymphocyte epitopes, observed in four cases, may be important in vaccine development. Peptide 36-52 was recognized by interleukin-2-producing peripheral blood T cells from 9 of 17 HIV-seropositive humans studied, of multiple human leukocyte antigen-DR and -DQ types. The broad recognition of this peptide by both helper and cytotoxic T cells substantiates its potential importance in a vaccine.
引用
收藏
页码:1058 / 1065
页数:8
相关论文
共 59 条
[1]  
BANGHAM CRM, 1986, J IMMUNOL, V137, P3973
[2]   HIV-1 REVERSE-TRANSCRIPTASE - STRUCTURE PREDICTIONS FOR THE POLYMERASE DOMAIN [J].
BARBER, AM ;
HIZI, A ;
MAIZEL, JV ;
HUGHES, SH .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (09) :1061-1072
[3]  
BERKOWER I, 1986, J IMMUNOL, V136, P2498
[4]   ANTIGENIC PEPTIDES RECOGNIZED BY LYMPHOCYTES-T FROM AIDS VIRAL ENVELOPE-IMMUNE HUMANS [J].
BERZOFSKY, JA ;
BENSUSSAN, A ;
CEASE, KB ;
BOURGE, JF ;
CHEYNIER, R ;
LURHUMA, Z ;
SALAUN, JJ ;
GALLO, RC ;
SHEARER, GM ;
ZAGURY, D .
NATURE, 1988, 334 (6184) :706-708
[5]   HELPER T-CELL ANTIGENIC SITE IDENTIFICATION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME VIRUS GP120 ENVELOPE PROTEIN AND INDUCTION OF IMMUNITY IN MICE TO THE NATIVE PROTEIN USING A 16-RESIDUE SYNTHETIC PEPTIDE [J].
CEASE, KB ;
MARGALIT, H ;
CORNETTE, JL ;
PUTNEY, SD ;
ROBEY, WG ;
OUYANG, C ;
STREICHER, HZ ;
FISCHINGER, PJ ;
GALLO, RC ;
DELISI, C ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (12) :4249-4253
[6]   HIV-1 REVERSE-TRANSCRIPTASE PURIFIED FROM A RECOMBINANT STRAIN OF ESCHERICHIA-COLI [J].
CLARK, PK ;
FERRIS, AL ;
MILLER, DA ;
HIZI, A ;
KIM, KW ;
DERINGERBOYER, SM ;
MELLINI, ML ;
CLARK, AD ;
ARNOLD, GF ;
LEBHERZ, WB ;
ARNOLD, E ;
MUSCHIK, GM ;
HUGHES, SH .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (06) :753-764
[7]   T-IMMUNOGENIC PEPTIDES ARE CONSTITUTED OF RARE SEQUENCE PATTERNS - USE IN THE IDENTIFICATION OF T-EPITOPES IN THE HUMAN IMMUNODEFICIENCY VIRUS GAG PROTEIN [J].
CLAVERIE, JM ;
KOURILSKY, P ;
LANGLADEDEMOYEN, P ;
CHALUFOURPROCHNICKA, A ;
DADAGLIO, G ;
TEKAIA, F ;
PLATA, F ;
BOUGUELERET, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1547-1553
[8]   INTERLEUKIN-2 PRODUCTION USED TO DETECT ANTIGENIC PEPTIDE RECOGNITION BY T-HELPER LYMPHOCYTES FROM ASYMPTOMATIC HIV-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
BERNSTEIN, DC ;
MANN, DL ;
SHEARER, GM ;
BERZOFSKY, JA .
NATURE, 1989, 339 (6223) :383-385
[9]   DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
LUCEY, DR ;
VIA, CS ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899
[10]  
CLERICI M, 1991, J IMMUNOL, V146, P2214